Results
1
Stocks where the price continues to rise after more than a year of consistent gains.
1 companies
Fusion Antibodies
Market Cap: UK£16.5m
A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.
FAB
UK£0.14
7D
34.9%
1Y
339.4%